Advertisement
UK markets close in 3 hours 58 minutes
  • FTSE 100

    8,237.62
    +32.51 (+0.40%)
     
  • FTSE 250

    20,470.22
    +89.17 (+0.44%)
     
  • AIM

    775.16
    -2.34 (-0.30%)
     
  • GBP/EUR

    1.1829
    -0.0005 (-0.04%)
     
  • GBP/USD

    1.2696
    -0.0026 (-0.20%)
     
  • Bitcoin GBP

    52,317.21
    +767.00 (+1.49%)
     
  • CMC Crypto 200

    1,379.63
    -3.03 (-0.22%)
     
  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     
  • DOW

    38,834.86
    +56.76 (+0.15%)
     
  • CRUDE OIL

    81.70
    +0.13 (+0.16%)
     
  • GOLD FUTURES

    2,351.80
    +4.90 (+0.21%)
     
  • NIKKEI 225

    38,633.02
    +62.26 (+0.16%)
     
  • HANG SENG

    18,335.32
    -95.07 (-0.52%)
     
  • DAX

    18,159.15
    +91.24 (+0.50%)
     
  • CAC 40

    7,645.20
    +75.00 (+0.99%)
     

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

Progyny
Progyny

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 A.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.

About Progyny

Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.

ADVERTISEMENT

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:

Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com